In the EU, it has been submitted to the European Medicines Agency for licensing approval and the regulatory agencies of each country will decide whether to approve it within their health systems
Boasting domestic manufacturing, ex-Novo Nordisk leadership and a market hungry for cheaper GLP-1s, Toronto start-up Vimy Pharma says it plans to produce a Canadian-made generic of Ozempic (semaglutide) as protections on the blockbuster diabetes/obesity drug unwind in Canada in early 2026
What makes the tablet possible is a delivery ingredient called SNAC
Why it matters: GLP-1s have been incredibly popularand theyre reshaping consumer spending habits
As the development of a sublingual delivery of biological GLP-1 receptor agonists heralds a new era in chronic disease management, the technology is poised to significantly improve quality of life for millions of patients worldwide
Cuidado de calidad para la prdida de peso, simplificado